The Clorox Company $CLX Shares Acquired by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. increased its holdings in The Clorox Company (NYSE:CLX) by 9.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 335,514 shares of the company’s stock after buying an additional 27,639 shares during the period. Nomura Asset Management Co. Ltd. owned about 0.27% of Clorox worth $40,285,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. OVERSEA CHINESE BANKING Corp Ltd purchased a new position in shares of Clorox during the 1st quarter worth approximately $369,000. Diversify Advisory Services LLC lifted its stake in Clorox by 13.9% in the 1st quarter. Diversify Advisory Services LLC now owns 1,913 shares of the company’s stock valued at $270,000 after buying an additional 233 shares in the last quarter. IFP Advisors Inc grew its holdings in Clorox by 7.6% during the 1st quarter. IFP Advisors Inc now owns 4,861 shares of the company’s stock valued at $716,000 after buying an additional 345 shares during the last quarter. J.W. Cole Advisors Inc. increased its position in Clorox by 278.0% during the first quarter. J.W. Cole Advisors Inc. now owns 7,417 shares of the company’s stock worth $1,092,000 after buying an additional 5,455 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky raised its holdings in shares of Clorox by 2.6% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,499 shares of the company’s stock worth $1,399,000 after acquiring an additional 243 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on CLX. The Goldman Sachs Group dropped their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. BNP Paribas Exane decreased their price target on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 28th. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. Finally, Bank of America cut their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $125.69.

Insider Buying and Selling

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.63% of the stock is owned by corporate insiders.

Clorox Price Performance

Clorox stock opened at $101.23 on Tuesday. The Clorox Company has a 1 year low of $101.11 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm has a 50 day moving average price of $117.18 and a 200 day moving average price of $123.22. The company has a market cap of $12.35 billion, a price-to-earnings ratio of 15.53, a PEG ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the business earned $1.86 EPS. Clorox’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd were given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s payout ratio is 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.